| 2025-10-28 |
详情>>
业绩披露：
2025年三季报(累计)每股收益0.15美元,归母净利润3.03亿美元,同比去年增长190.58%
|
| 2025-10-28 |
财报披露：
美东时间 2025-10-28 盘后发布财报
|
| 2025-07-29 |
详情>>
业绩披露：
2025年中报每股收益0.14美元,归母净利润2.82亿美元,同比去年增长177.01%
|
| 2025-04-30 |
详情>>
业绩披露：
2025年一季报每股收益0.03美元,归母净利润6697.80万美元,同比去年增长-81.47%
|
| 2025-03-28 |
详情>>
业绩披露：
2024年年报每股收益-0.03美元,归母净利润-5367.2万美元,同比去年增长-107.94%
|
| 2025-03-28 |
详情>>
业绩披露：
2022年年报每股收益0.90美元,归母净利润17.68亿美元,同比去年增长-53.79%
|
| 2024-11-06 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.17美元,归母净利润-3.35亿美元,同比去年增长-227.68%
|
| 2024-07-31 |
详情>>
业绩披露：
2024年中报每股收益-0.19美元,归母净利润-3.66亿美元,同比去年增长-136.57%
|
| 2024-04-25 |
详情>>
业绩披露：
2024年一季报每股收益0.18美元,归母净利润3.61亿美元,同比去年增长-3.46%
|
| 2024-03-28 |
详情>>
业绩披露：
2023年年报每股收益0.34美元,归母净利润6.76亿美元,同比去年增长-61.75%
|
| 2024-03-18 |
股东大会：
将于2024-04-30召开股东大会
会议内容 ▼▲
- 1.Consideration of the Company’s 2023 Annual Report containing the consolidated management report and independent auditors report on the Company’s consolidated financial statements as of December 31, 2023; and the Company’s annual accounts as of December 31, 2023 and the independent auditors report thereon. Approval of the Company’s consolidated financial statements as of December 31, 2023 and 2022 and for the years ended December 31, 2023, 2022 and 2021.
2.Consideration of the independent auditor’s report on the Company’s annual accounts. Approval of the Company’s annual accounts as at December 31, 2023.
3.Allocation of results for the year ended December 31, 2023.
4.Discharge of members of the Board of Directors for the exercise of their mandate during the year ended December 31, 2023.
5.Election of the members of the Board of Directors.
6.Authorization of the compensation to the members of the Board of Directors for the year 2024.
7.Appointment of the independent auditors for the fiscal year ending December 31, 2024 and approval of their fees.
8.Authorization to the Board of Directors to appoint one or more of its members as the Company’s attorney-in-fact.
|
| 2023-10-31 |
详情>>
业绩披露：
2023年三季报(累计)每股收益0.13美元,归母净利润2.62亿美元,同比去年增长-84.84%
|
| 2023-03-17 |
股东大会：
将于2023-05-02召开股东大会
会议内容 ▼▲
- 1.Consideration of the Company’s 2022 Annual Report containing the consolidated management report and independent auditors report on the Company’s consolidated financial statements as of December 31, 2022; and the Company’s annual accounts as of December 31, 2022 and the independent auditors report thereon. Approval of the Company’s consolidated financial statements as of December 31, 2022 and 2021 and for the years ended December 31, 2022, 2021 and 2020.
2.Consideration of the independent auditor’s report on the Company’s annual accounts. Approval of the Company’s annual accounts as at December 31, 2022.
3.Allocation of results for the year ended December 31, 2022.
4.Discharge of members of the Board of Directors for the exercise of their mandate during the year ended December 31, 2022.
5.Election of the members of the Board of Directors.
6.Authorization of the compensation to the members of the Board of Directors for the year 2023.
7.Appointment of the independent auditors for the fiscal year ending December 31, 2023 and approval of their fees.
8.Authorization to the Board of Directors to appoint one or more of its members as the Company’s attorney-in-fact.
|
| 2022-03-30 |
详情>>
股本变动：
变动后总股本20047.43万股
|
| 2022-03-18 |
股东大会：
将于2022-05-03召开股东大会
会议内容 ▼▲
- 1.Consideration of the Consolidated Management’s and independent auditor’s reports on the Company’s consolidated financial statements. Approval of the Company’s consolidated financial statements as of December 31, 2021 and 2020 and for the years ended December 31, 2021, 2020 and 2019.
2.Consideration of the independent auditor’s report on the Company’s annual accounts. Approval of the Company’s annual accounts as at December 31, 2021.
3.Allocation of results for the year ended December 31, 2021.
4.Discharge of members of the Board of Directors for the exercise of their mandate during the year ended December 31, 2021.
5.Election of the members of the Board of Directors.
6.Authorization of the compensation to the members of the Board of Directors for the year 2022.
7.Appointment of the independent auditors for the fiscal year ending December 31, 2022 and approval of their fees.
8.Authorization to the Board of Directors to appoint one or more of its members as the Company’s attorney-in-fact.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-03-18 |
股东大会：
将于2021-05-03召开股东大会
会议内容 ▼▲
- 1.Consideration of the Consolidated Management’s and independent auditor’s reports on the Company’s consolidated financial statements. Approval of the Company’s consolidated financial statements as of December 31, 2020 and 2019 and for the years ended December 31, 2020, 2019 and 2018.
2.Consideration of the independent auditor’s report on the Company’s annual accounts. Approval of the Company’s annual accounts as at December 31, 2020.
3.Allocation of results for the year ended December 31, 2020.
4.Discharge of members of the Board of Directors for the exercise of their mandate during the year ended December 31, 2020.
5.Election of the members of the Board of Directors.
6.Authorization of an additional compensation to the members of the Board of Directors for the year 2020.
7.Authorization of the compensation to the members of the Board of Directors for the year 2021.
8.Appointment of the independent auditors for the fiscal year ending December 31, 2021 and approval of their fees.
9.Authorization to the Company, or any subsidiary, from time to time to purchase, acquire or receive securities of the Company, in accordance with Article 430-15 of the Luxembourg law of 10 August 1915 on commercial companies, as amended (the “Company Law”) and with applicable laws and regulations.
10.Authorization to the Board of Directors to appoint one or more of its members as the Company’s attorney-in-fact.
|
| 2020-04-28 |
股东大会：
将于2020-06-05召开股东大会
会议内容 ▼▲
- 1.Consideration of the Board of Directors’ and independent auditor’s reports on the Company’s consolidated financial statements. Approval of the Company’s consolidated financial statements as of December 31, 2019 and 2018 and for the years ended December 31, 2019, 2018 and 2017.
2.Consideration of the independent auditor’s report on the Company’s annual accounts. Approval of the Company’s annual accounts as at December 31, 2019.
3.Allocation of results and approval of dividend payment for the year ended December 31, 2019.
4.Discharge of members of the Board of Directors for the exercise of their mandate during the year ended December 31, 2019.
5.Election of the members of the Board of Directors.
6.Authorization of the compensation of the members of the Board of Directors.
7.Appointment of the independent auditors for the fiscal year ending December 31, 2020 and approval of their fees.
8.Authorization to the Board of Directors to appoint one or more of its members as the Company’s attorney-in-fact.
|
| 2019-03-19 |
股东大会：
将于2019-05-06召开股东大会
会议内容 ▼▲
- 1.Consideration of the Board of Directors’ and independent auditor’s reports on the Company’s consolidated financial statements. Approval of the Company’s consolidated financial statements as of December 31, 2018 and 2017 and for the years ended December 31, 2018, 2017 and 2016.
2.Consideration of the independent auditor’s report on the Company’s annual accounts. Approval of the Company’s annual accounts as at December 31, 2018.
3.Allocation of results and approval of dividend payment for the year ended December 31, 2018.
4.Discharge of members of the Board of Directors for the exercise of their mandate during the year ended December 31, 2018.
5.Election of the members of the Board of Directors.
6.Authorization of the compensation of the members of the Board of Directors.
7.Appointment of the independent auditors for the fiscal year ending December 31, 2019 and approval of their fees.
8.Authorization to the Board of Directors to appoint one or more of its members as the Company’s attorney-in-fact.
|
| 2019-02-19 |
除权日：
美东时间 2019-05-08 每股派息1.20美元
|
| 2018-11-28 |
复牌提示：
2018-11-27 15:32:40 停牌，复牌日期 2018-11-28 07:22:51
|
| 2018-03-22 |
股东大会：
将于2018-05-02召开股东大会
会议内容 ▼▲
- 1.Consideration of the Board of Directors’ and independent auditor’s reports on the Company’s consolidated financial statements. Approval of the Company’s consolidated financial statements as of December 31, 2017 and 2016 and for the years ended December 31, 2017, 2016 and 2015.
2.Consideration of the independent auditor’s report on the Company’s annual accounts. Approval of the Company’s annual accounts as at December 31, 2017.
3.Allocation of results and approval of dividend payment for the year ended December 31, 2017.
4.Discharge of members of the Board of Directors for the exercise of their mandate during the year ended December 31, 2017.
5.Election of the members of the Board of Directors.
6.Authorization of the compensation of the members of the Board of Directors.
7.Appointment of the independent auditors for the fiscal year ending December 31, 2018 and approval of their fees.
8.Authorization to the Board of Directors to appoint one or more of its members as the Company’s attorney-in-fact.
|
| 2018-03-22 |
股东大会：
将于2018-05-02召开股东大会
会议内容 ▼▲
- 1.Consideration of the Board of Directors’ and independent auditor’s reports on the Company’s consolidated financial statements. Approval of the Company’s consolidated financial statements as of December 31, 2017 and 2016 and for the years ended December 31, 2017, 2016 and 2015.
2.Consideration of the independent auditor’s report on the Company’s annual accounts. Approval of the Company’s annual accounts as at December 31, 2017.
3.Allocation of results and approval of dividend payment for the year ended December 31, 2017.
4.Discharge of members of the Board of Directors for the exercise of their mandate during the year ended December 31, 2017.
5.Election of the members of the Board of Directors.
6.Authorization of the compensation of the members of the Board of Directors.
7.Appointment of the independent auditors for the fiscal year ending December 31, 2018 and approval of their fees.
8.Authorization to the Board of Directors to appoint one or more of its members as the Company’s attorney-in-fact.
|
| 2018-02-20 |
除权日：
美东时间 2018-05-04 每股派息1.10美元
|
| 2017-03-21 |
股东大会：
将于2017-05-03召开股东大会
会议内容 ▼▲
- 1.Consideration of the Board of Directors’ and independent auditor’s reports on the Company’s consolidated financial statements. Approval of the Company’s consolidated financial statements as of December 31, 2016 and 2015 and for the years ended December 31, 2016, 2015 and 2014.
2.Consideration of the independent auditor’s report on the Company’s annual accounts. Approval of the Company’s annual accounts as at December 31, 2016.
3.Allocation of results and approval of dividend payment for the year ended December 31, 2016.
4.Discharge of members of the Board of Directors for the exercise of their mandate during the year ended December 31, 2016.
5.Election of the members of the Board of Directors.
6.Authorization of the compensation of the members of the Board of Directors.
7.Appointment of the independent auditors for the fiscal year ending December 31, 2017 and approval of their fees.
8.Authorization to the Board of Directors to delegate the day-to-day management of the Company’s business to one or more of its members.
9.Authorization to the Board of Directors to appoint one or more of its members as the Company’s attorney-in-fact.
|
| 2017-02-21 |
除权日：
美东时间 2017-05-05 每股派息1.00美元
|
| 2016-03-30 |
股东大会：
将于2016-05-04召开股东大会
会议内容 ▼▲
- 1. Consideration of the Board of Directors’ and independent auditor’s reports on the Company’s consolidated financial statements. Approval of the Company’s consolidated financial statements as of December 31, 2015 and 2014 and for the years ended December 31, 2015, 2014 and 2013.
2. Consideration of the independent auditor’s report on the Company’s annual accounts. Approval of the Company’s annual accounts as at December 31, 2015.
3. Allocation of results and approval of dividend payment for the year ended December 31, 2015.
4. Discharge of members of the Board of Directors for the exercise of their mandate during the year ended December 31, 2015.
5. Election of the members of the Board of Directors.
6. Authorization of the compensation of the members of the Board of Directors.
7. Appointment of the independent auditors for the fiscal year ending December 31, 2016 and approval of their fees.
8. Authorization to the Board of Directors to delegate the day-to-day management of the Company’s business to one or more of its members.
9. Authorization to the Board of Directors to appoint one or more of its members as the Company’s attorney-in-fact.
|
| 2016-02-23 |
除权日：
美东时间 2016-05-06 每股派息0.90美元
|
| 2015-03-30 |
股东大会：
将于2015-05-06召开股东大会
会议内容 ▼▲
- Agenda for the Annual General Meeting of Shareholders
1. Consideration of the Board of Directors’ and independent auditor’s reports on the Company’s consolidated financial statements. Approval of the Company’s consolidated financial statements as of December 31, 2014 and 2013 and for the years ended December 31, 2014, 2013 and 2012.
2. Consideration of the independent auditor’s report on the Company’s annual accounts. Approval of the Company’s annual accounts as at December 31, 2014.
3. Allocation of results and approval of dividend payment for the year ended December 31, 2014.
4. Discharge of members of the Board of Directors for the exercise of their mandate during the year ended December 31, 2014.
5. Election of the members of the Board of Directors.
6. Authorization of the compensation of the members of the Board of Directors.
7. Appointment of the independent auditors for the fiscal year ending December 31, 2015 and approval of their fees.
8. Authorization to the Company, or any subsidiary, from time to time to purchase, acquire or receive securities of the Company, in accordance with Article 49-2 of the Luxembourg law of 10 August 1915 and with applicable laws and regulations.
9. Authorization to the Board of Directors to delegate the day-to-day management of the Company’s business to one or more of its members.
10. Authorization to the Board of Directors to appoint one or more of its members as the Company’s attorney-in-fact.
Agenda for the Extraordinary General Meeting of Shareholders
1. Decision on the renewal of the authorized share capital of the Company and related authorizations and waivers by:
a. the renewal of the validity period of the Company’s authorized share capital for a period starting on the date of the Extraordinary General Meeting of Shareholders and ending on the fifth anniversary of the date of the publication in the Mémorial of the deed recording the minutes of such meeting;
b. the renewal of the authorization to the Board of Directors, or any delegate(s) duly appointed by the Board of Directors, for a period starting on the date of the Extraordinary General Meeting of Shareholders and ending on the fifth anniversary of the date of the publication in the Mémorial of the deed recording the minutes of such meeting, from time to time to issue shares within the limits of the authorized share capital against contributions in cash, contributions in kind or by way of incorporation of available reserves at such times and on such terms and conditions, including the issue price, as the Board of Directors or its delegate(s) may in its or their discretion resolve;
c. the renewal of the authorization to the Board of Directors, for a period starting on the date of the Extraordinary General Meeting of Shareholders and ending on the fifth anniversary of the date of the publication in the Mémorial of the deed recording the minutes of such meeting, to waive, suppress or limit any pre-emptive subscription rights of shareholders provided for by law to the extent it deems such waiver, suppression or limitation advisable for any issue or issues of shares within the authorized share capital; waiver of any pre-emptive subscription rights provided for by law and related procedures;
d. the decision that for as long as (but only for as long as) the shares of the Company are listed on a regulated market, any issuance of shares for cash within the limits of the authorized share capital shall be subject by provision of the Company’s articles of association to the pre-emptive subscription rights of the then existing shareholders, except in the following cases (in which cases no pre-emptive rights shall apply):
i. any issuance of shares for, within, in conjunction with or related to, an initial public offering of the shares of the Company on one or more regulated markets (in one or more instances);
ii. any issuance of shares against a contribution other than in cash;
iii. any issuance of shares upon conversion of convertible bonds or other instruments convertible into shares of the Company; provided, however, that the pre-emptive subscription rights of the then existing shareholders shall apply by provision of the Company’s articles of association in connection with any issuance of convertible bonds or other instruments convertible into shares of the Company for cash;
iv. any issuance of shares (including by way of free shares or at discount), up to an amount of 1.5% of the issued share capital of the Company, to directors, officers, agents, employees of the Company, its direct or indirect subsidiaries, or its Affiliates (as such term is defined in the Company’s articles of association) (collectively, the "Beneficiaries"), including without limitation the direct issue of shares or upon the exercise of options, rights convertible into shares, or similar instruments convertible or exchangeable into shares issued for the purpose of compensation or incentive of the Beneficiaries or in relation thereto (which the Board of Directors shall be authorized to issue upon such terms and conditions as it deems fit).
e. the acknowledgement and approval of the report of the Board of Directors in relation with the authorized share capital and the proposed authorizations to the Board of Directors with respect to any issuance of shares within the authorized share capital while suppressing any pre-emptive subscription rights of existing shareholders under law and related waiver;
f. the amendment of article 5 of the articles of association of the Company to reflect the resolutions on this item of the agenda.
|
| 2015-02-19 |
除权日：
美东时间 2015-05-08 每股派息0.90美元
|
| 2014-04-01 |
除权日：
美东时间 2014-05-09 每股派息0.75美元
|
| 2014-03-27 |
股东大会：
将于2014-05-07召开股东大会
会议内容 ▼▲
- 1. Consideration of the Board of Directors’ and independent auditor’s reports on the Company’s consolidated financial statements. Approval of the Company’s consolidated financial statements as of December 31, 2013 and 2012 and for the years ended December 31, 2013, 2012 and 2011.
2. Consideration of the independent auditor’s report on the Company’s annual accounts. Approval of the Company’s annual accounts as at December 31, 2013.
3. Allocation of results and approval of dividend payment.
4. Discharge to the members of the Board of Directors for the exercise of their mandate throughout the year ended December 31, 2013.
5. Election of the members of the Board of Directors.
6. Compensation of the members of the Board of Directors.
7. Appointment of the independent auditors for the fiscal year ending December 31, 2014 and approval of their fees.
8. Authorization to the Board of Directors to delegate the day-to-day management of the Company’s business to one or more of its members.
9. Authorization to the Board of Directors to appoint one or more of its members as the Company’s attorney-in-fact.
|
| 2013-04-26 |
除权日：
美东时间 2013-05-03 每股派息0.65美元
|
| 2012-03-29 |
除权日：
美东时间 2012-05-03 每股派息0.75美元
|
| 2011-06-01 |
除权日：
美东时间 2011-06-02 每股派息0.75美元
|
| 2010-05-22 |
除权日：
美东时间 2010-06-03 每股派息0.50美元
|